Person:
BÜYÜKPINARBAŞILI, NUR

Loading...
Profile Picture

Status

Kurumdan Ayrılmıştır

Email Address

Birth Date

Name

Job Title

First Name

NUR

Last Name

BÜYÜKPINARBAŞILI

Organizational Units

Organizational Unit

Search Results

Now showing 1 - 9 of 9
  • PublicationOpen Access
    A Rare Case: Mucous Membrane Plasmacytosis in the Larynx
    (2014-07-01) BÜYÜKPINARBAŞILI, NUR; ÇOBAN, GANİME; GÜCİN, ZÜHAL; Meriç, Ayşenur; BÜYÜKPINARBAŞILI, NUR; ÇOBAN, GANİME; GÜCİN, ZÜHAL
    Mucous membrane plasmacytosis is a rare reactive process characterized by plasma cell infiltration of mucous membranes for unknown reasons. It may be confused with malignancy because of its exophytic structure and pavement appereances. A laryngeal polypoid lesion was sent to the pathology department, clinically called fibroma, and presented to emphasize the diagnostic and differential diagnostic criteria.
  • Publication
    Crucial Roles of Systemic and Tissue Lipid Peroxidation Levels and Anti-Oxidant Defences Following Contrast Agent Application
    (2016-06-01T00:00:00Z) Sitar, Gungor; Kucuk, Mehmet; Sitar, Mustafa Erinc; Yasar, Ozgur; AYDIN, Seval; YANAR, Karolin; ÇAKATAY, Ufuk; BÜYÜKPINARBAŞILI, NUR; BÜYÜKPINARBAŞILI, NUR
    Background: One of the most important side effects of contrast pharmaceutical agents, which are used very common in routine radiology practice, is contrast induced nephropathy. Even ischemia, oxidative stress and osmolality related cytotoxic effects are considered, the molecular mechanisms underlying this pathology have not been identified completely yet.
  • Publication
    Triple-negative breast cancer presented with metastasis to the heart as first sign of recurrence
    (2020-10-01T00:00:00Z) Bayramgil, Ayberk; Bilici, Ahmet; Hamdard, Jamshid; Acikgoz, Ozgur; Seker, Mehmet; Kilicaslan, Fethi; KÖKSAL, CENGİZ; BÜYÜKPINARBAŞILI, NUR; Mammadov, Elkhan; Goktas Aydin, Sabin; Olmez, Omer Fatih; Yildiz, Ozcan; KÖKSAL, CENGİZ; BÜYÜKPINARBAŞILI, NUR
  • Publication
    Sarkoidosis presenting with pleural involvement
    (2014-12-01) KUTBAY OZCELIK, HATICE; BAYRAM, MEHMET; BÜYÜKPINARBAŞILI, NUR; KANSU, ABDULLAH; AKKOYUNLU, MUHAMMED EMİN; SEZER, M; OKYALTIRIK, FATMANUR; YAKAR, FATİH; KART, L; BAYRAM, MEHMET; BÜYÜKPINARBAŞILI, NUR; KANSU, ABDULLAH; AKKOYUNLU, MUHAMMED EMİN; OKYALTIRIK, FATMANUR
  • Publication
    The Association Between Paranasal Mucous Retention Cysts and Allergic Sensitization
    (2021-01-01T00:00:00Z) USTABAŞ KAHRAMAN, Feyza; YAZICI, MEBRURE; BÜYÜKPINARBAŞILI, NUR; Soylu, Nihal; İŞCAN, AKIN; ÖZKAYA, EMİN; USTABAŞ KAHRAMAN, FEYZA; YAZICI, MEBRURE; BÜYÜKPINARBAŞILI, NUR; İŞCAN, AKIN; ÖZKAYA, EMİN
    Objective: Although there is no consensus regarding the etiology of paranasal mucous retention cysts (MRCs) in the literature, several studies suggest an allergic etiology. This study aimed to investigate a potential association between paranasal MRCs diagnosed with MRI scans and allergic sensitization in the pediatric population.
  • Publication
    Does Every Necrotizing Granulomatous Inflammation Identified by NSCLC Resection Material Require Treatment?
    (2016-04-01T00:00:00Z) Yakar, Fatih; Yakar, Aysun; BÜYÜKPINARBAŞILI, NUR; Erelel, Mustafa; BÜYÜKPINARBAŞILI, NUR
    Background: Lung cancer and tuberculosis (TB) are two major public health problems. They can coexist or appear sequentially. In patients with TB, lung cancer risk is increased. However, vice versa is not crystal clear. In this study, we aimed to determine the development of TB in patients with resectabled non-small cell lung cancer (NSCLC) in a 2-year postoperative follow-up period.
  • PublicationOpen Access
    Immunoexpression of TTF-1 in Non-Lung Tumors
    (2014-12-01T00:00:00Z) TOSUNER, ZEYNEP; ARICI, Dilek Sema; GÜCİN, ZÜHAL; BÜYÜKPINARBAŞILI, NUR; SÖNMEZ, FATMA CAVİDE; YILDIZ, PELİN; TOSUNER, ZEYNEP; ARICI, DILEK SEMA; GÜCİN, ZÜHAL; BÜYÜKPINARBAŞILI, NUR; SÖNMEZ, FATMA CAVİDE; YILDIZ, PELİN
    Objective: Thyroid transcription factor-1 (TTF-1) immunoexpression is frequently determined in small-cell lung carcinomas, as well as primary lung adenocarcinomas. While dealing with metastatic carcinomas, TTF-1 immunoexpression is a significant indicator of primary lung carcinomas. Recent studies have revealed that TTF-1 immunoexpression is also defined in non-lung cancers, such as squamous cell carcinomas of different sites and certain neuroendocrine tumors. The verified data obtained from these studies indicate that a straightforward diagnosis of primary lung carcinoma in cases with positive TTF-1 immunoexpression can cause diagnostic contradictions. The aim of our study is to investigate the immunoexpression status of TTF-1 in common non-lung tumors. Methods: A total of 85 cases that were diagnosed in our institute between the years 2011-2012 were included in our study. After a review of the pathological slides prepared from these tumors [colon adenocarcinoma (n: 15), renal cell carcinoma (n: 15), prostate adenocarcinoma (n: 15), invasive papillary urothelial carcinoma (n: 15), invasive ductal carcinoma of breast (n: 15), and neuroendocrine tumors (n: 10)] TTF-1 immunohistochemistry was applied. Semiquantative evaluation based on the distribution and intensity of the staining was performed by two pathologists, respectively. Results: Positive immunostaining was evident in only 1 case of colon adenocarcinoma out of 85 cases. Conclusion: Our study demonstrated that TTF-1 immunoexpression is a very rare finding (1%) in non-lung tumors. This result provides that anti-TTF-1 is a reliable antibody in the interpretation of primary lung carcinomas. In fact, further studies with a large number of cases are needed to confirm the sensitivity and specificity of TTF-1.
  • PublicationOpen Access
    Helicobacter pylori as an Etiologic Factor in Primary Lung Carcinoma
    (2018-04-01T00:00:00Z) BÜYÜKPINARBAŞILI, NUR; BÜYÜKPINARBAŞILI, NUR
    Objective: Although the importance of environmental and occupational exposure to carcinogenic agents in pulmonary carcinoma is well known, some other factors, such as familial predisposition, genetic abnormalities, and recently, the presence of Helicobacter pylori infection, are being disputed. This study focused on the relationship between pulmonary carcinoma and H. pylori infection. Methods: In total, 48 histologically verified and operated patients with pulmonary carcinoma, including 38 males and 10 females, were included; 22 of the cases were of squamous cell carcinomas and 26 were adenocarcinomas. The control group composed of 20 patients who underwent pulmonary operation for causes other than lung cancer. Adjacent non-neoplastic parenchymal and bronchial tissue examples were stained using the Giemsa stain in carcinoma cases. The pulmonary tissue-contained bronchial sections were stained in control cases. The bronchial epithelia and lumina in the Giemsa stained slides were examined for H. pylori bacilli. Results: H. pylori was found in 2 of 48 carcinoma cases. The histopathological diagnosis of these 2 cases was squamous cell carcinoma. But there wasn't any case stained for H.pylori in the control group. Conclusion: The relationship between pulmonary carcinoma and H. pylori infection had been researched through serological studies; however, conflicting evidences have been obtained. The bacterium is transmitted to the lungs via seeding and inhalation was reported to be effective directly. Chronic H. pylori infection leads to bronchial epithelial proliferation via increased gastrin level and cyclooxygenase-2. Moreover, it contributes to pulmonary carcinogenesis. In conclusion, an association between H. pylori infection and pulmonary carcinoma may be revealed by variable studies, and the underlying mechanisms can be understood.
  • Publication
    An unusual liver mass: primary malignant mesothelioma of the liver
    (2015-02-01T00:00:00Z) Serter, Asli; BÜYÜKPINARBAŞILI, NUR; Karatepe, Oguzhan; KOCAKOÇ, ERCAN; BÜYÜKPINARBAŞILI, NUR; KOCAKOÇ, ERCAN
    Primary malignant mesothelioma of the liver is extremely rare, and radiologic features have been defined in only one case. We present radiologic findings of two cases which are pathologically proven as primary malignant mesothelioma of the liver. Malignant mesothelioma of the liver may be included in a differential diagnosis list if there is a heterogeneous, hemorrhagic and necrotic lesion in the liver, with peripheral serpiginous vascular structures and increasing septal enhancement in post-contrast images.